echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Millions of new crown deaths worldwide Experts are calling for attention to be paid to saving lives.

    Millions of new crown deaths worldwide Experts are calling for attention to be paid to saving lives.

    • Last Update: 2020-10-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    World Health Organization statistics show that the world's new crown deaths have exceeded 1 million cases, the cumulative number of confirmed cases of nearly 33.25 million cases.
    In the past week, there have been more than 2 million new confirmed cases and more than 364,000 new deaths worldwide, with more than half of the additions coming from countries in the Americas in the six regions of the world classified by WHO.
    WHO experts say the current statistics still underestimate the severity of the outbreak and that attention should be given to saving lives and preventing transmission with the means and methods available before the new vaccine is officially available.
    WHO Director-General Tan Desser said the same day, 1 million people died in the new crown "is a difficult time for the world, but there is still a 3rd possible hope to inspire us now and in the near future."
    he called on all countries, communities and individuals to focus on four basic measures to control the outbreak.
    First, to avoid activities that cause the spread of the epidemic, second, to reduce deaths by protecting high-risk groups such as the elderly, people with underlying diseases, practitioners in key industries, and third, individuals must take known and effective measures to protect themselves and others, including maintaining at least one metre of distance, washing their hands, wearing masks, and avoiding crowded places, close contact, etc.;
    Ryan, executive director of THE WHO's emergency programme, said it was "certainly inconceivable, but not impossible", that 2m deaths worldwide would be possible before the safe and effective new crown vaccine was officially available.
    The reality is that 1 million people have lost their lives in the last nine months, and getting a vaccine in the next nine months is a daunting task for everyone."
    stressed that while 1 million is a terrible number, there is much more we can do in terms of outbreak control, existing rescue measures and innovations to fight the epidemic.
    , for example, are doing better than ever in using treatments such as oxygen transfusion, intensive care and dexamisong, so clinical death rates are slowly declining.
    he called for increased support for the WHO-led International Cooperation Initiative for Access to tools to fight the new coronary pneumonia, with multilateral action and global collective action to control the virus.
    Who's Senior Adviser to the Director-General of WHO, Bruce Aylward, said: "Whether another 1 million people die from new crowns depends not on whether we have a vaccine, but on whether we use the tools, methods and knowledge available to save lives and prevent transmission."
    ," he said.
    we have made incredible progress in reducing the death rate of new coronary diseases and in preventing infections in the most vulnerable and at risk.
    , as of 28 September, 40 new crown vaccine candidates have been reported to WHO in the clinical trial phase, 10 of which have entered Phase 3 clinical trials, according to WHO.
    WHO said recently that the GLOBAL New Crown Vaccine Program, co-led by the organization and its partners, will begin signing formal agreements with vaccine manufacturers and developers to ensure that at least 2 billion doses of safe and effective new crown vaccines are delivered globally by 2021.
    , regardless of which vaccine is proven to be safe and effective in the future, participating countries have timely access to vaccines, whether low- and middle-income countries or high-income countries.
    WHO Assistant Director-General Marian hera Simo said that despite the large number of vaccine candidates, WHO, partners, manufacturers and others would never compromise on safety and effectiveness in order to launch the vaccine as soon as possible, and that all clinical trials must be completed and met before the vaccine could be considered for market, so the general public need not worry about its safety and effectiveness due to accelerated vaccine development.
    Liu Qu Source: Xinhua News Agency Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Original" are owned by Metz Medical and may not be reproduced by any media, website or individual without authorization.
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    reproduce content at the same time does not represent the position of this site.
    leave a message here.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.